Skip to main content
. 2019 Jul-Sep;63(3):249–256.

Table 1.

Demographic profile of subjects

Controls Polyquad BAK
Patients (number) 30 40 40
Age (Years) 60.42 ± 7.16 61.25 ± 13.32 60.88 ± 8.48
Gender (Male/ Female) 18/ 12 25/ 15 24/ 16
Treatment Duration (months) - 12.83 ± 7.63 15.65 ± 9.62
IOP (mmHg) Baseline 13.3 ± 2.6 20.1 ± 4.2 19.2 ± 3.5
12 months 14 ± 2.4 12.8 ± 3.3 13.2 ± 2.1